ClinicalTrials.gg
CompletedNCT07495683MATCH-PIPUpdated Mar 27, 2026

Personalizing Psychosocial Intervention for Children With Disruptive Behaviour

An interventional study of Behavioral Parent Training in Behavioural Disorder, Disruptive Behavior Disorder and Attention Deficit Hyperactivity Disorder, sponsored by Centre for Addiction and Mental Health. Completed. Open to participants aged 6 Years to 12 Years. Per ClinicalTrials.gov, last updated 2026-03-27.

Primary conditionAttention Deficit and Disruptive Behavior DisordersRegistry: Mental DisordersReclassifiedWhy we changed it
Registry
Mental Disorders — the first condition term the registry derived for this study.
ClinicalTrials.gg
Attention Deficit and Disruptive Behavior Disorders
Why
  1. The study's listed conditions name Attention Deficit and Disruptive Behavior Disorders, a narrower term within Mental Disorders.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Centre for Addiction and Mental Health · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 7 years 9 months after the study started (first participant enrolled Sep 2016, registered Jun 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
600
Allocation
Not applicable
Ages
6 Years to 12 Years
Sex
All
01

Study summary

This study will develop and test whether personalized profiles of children with Disruptive Behaviour Disorder (DBD) and their parents based on important psychological, emotional, and neuropsychological indicators predict their response to child cognitive behavioral treatment and Behavioral Parent Training (BPT).

Read the detailed description

To accomplish these goals, the investigators will collect psychological, emotional, and neuropsychological measures before and following cognitive behavioural therapy (CBT) for both children and parents. The investigators will use statistical modeling to determine profiles of parents of children and children aged 6-12 years with DBD based on key domains of mental health, emotion regulation, cognition, and parent-child behaviour, and observe whether these profiles allow the study team to predict which sub-groups of parents and children are most and least likely to benefit from child CBT and Behavioural Parent Training (BPT).

02

Conditions studied

  • Behavioural Disorder
  • Disruptive Behavior Disorder
  • Attention Deficit Hyperactivity Disorder
  • Conduct Disorder
  • Oppositional Defiant Disorder
  • Emotional Disorder

Keywords

  • Disruptive Behaviour Disorder
  • Attention Deficit Hyperactivity Disorder
  • Conduct Disorder
  • Oppositional Defiant Disorder
  • Parenting Skills
  • Behavioural Parenting Training
03

In context

Attention Deficit and Disruptive Behavior Disorders Reclassified

60 studies on the registry are indexed under Attention Deficit and Disruptive Behavior Disorders; 7 are open to participants now.

This study's enrollment of 600 is above the median of 100 across 51 interventional studies indexed under Attention Deficit and Disruptive Behavior Disorders.

Browse Attention Deficit and Disruptive Behavior Disorders studies →

Lead sponsor

Centre for Addiction and Mental Health is the lead sponsor of 339 studies on the registry; 51 are open to participants now.

Compared within Attention Deficit and Disruptive Behavior Disorders, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Mental Disorders. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
6 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of Oppositional Defiant Disorder (ODD), Conduct Disorder (CD) or Attention Deficit Hyperactivity Disorder (ADHD) determined by the supervising Clinical Psychologist based on diagnostic criteria on the C-DISC; and/or clinically at risk symptoms on the Child Behavior Checklist/Teacher Report Form (t score > 60)
  • Clinically severe impairment in social, family, peer functioning demonstrated by the parent- and teacher-completed Impairment Rating Scale (IRS) or the virtually administered Columbia Impairment Scale (CIS)
  • No evidence of Autism Spectrum Disorder (based on parent and teacher report) or Intellectual Disability (based on the Kaufman Brief Intelligence Task-II OR school reports or psychoeducational assessments).

Exclusion criteria

Exclusion Criteria

  • Presence of Autism or Intellectual Disability
  • Evidence of cognitive delays or an intellectual disability (based on the Kaufman Brief Intelligence Test-2 (KBIT-2), verbal and/or IQ composite standard score below 80 or collateral information)
  • Child behaviour or emotional functioning that make group participation not possible
  • Child preference for individual treatment.
  • Parent behaviour or emotional functioning that make group participation not possible
  • Parent preference for individual treatment.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
600 participants (actual)

Study arms

  • Experimental
    Multi-Component Child and Parent Cognitive Behavioral Therapy

    Parents and their children aged 6-12 with DBD who meet inclusion criteria.

    Behavioral: Behavioral Parent Training

Interventions

  • BehavioralBehavioral Parent Training

    Two 15-session multi-component cognitive-behavioral group treatments for children with disruptive behavior and their parents (i.e., one program for children aged 6-8 years and their parents and another for children aged 9-12 years and their parents. The programs have a child and parent group that are implemented concurrently.

06

What researchers measure

Primary outcomes

  1. Changes in child emotional and behavioral problems between baseline, post-treatment, and follow-up

    Changes in child emotional and behavioral problems are assessed using the Strengths and Difficulties Questionnaire (SDQ). It asks parents to indicate how true a statement is with regards to their child's emotions or behaviours in the last 6 months: 'not true', 'somewhat true', or 'certainly true'.

    Time frame: Baseline (prior to treatment), post-treatment (within 30 days post-intervention completion) and follow-up (1 year post-treatment completion)

  2. Changes in parenting skills between baseline, post-treatment, and follow-up

    Parenting skills are assessed using the Alabama Parenting Questionnaire (APQ). Parents indicate how often an item typically occurs in their home: 'never', 'almost never', 'sometimes', 'often', or 'always'. Each answer corresponds to a score: never = 1, almost never = 2, sometimes = 3, often = 4, and always = 5. The APQ has 3 subscales: positive parenting, inconsistent discipline, and poor supervision. Higher scores on the positive parenting subscale means greater positive parenting skills. Higher scores on the inconsistent discipline subscale means greater instances of inconsistent discipline. Higher scores on the poor supervision subscale means greater instances of poor supervision.

    Time frame: Baseline (prior to treatment), post-treatment (within 30 days of treatment completion) and follow-up (1 year after treatment completion)

  3. Changes in parenting competencies between baseline, post-treatment, and follow-up

    Parenting competencies are assessed using the Parenting Sense of Competence (PSOC). Parents indicate how much they agree with statements: 'strongly disagree', 'disagree', 'slightly disagree', 'slightly agree', 'agree', or 'strongly agree'. Higher scores on the PSOC indicate higher parenting sense of competence with scores ranging from a minimum of 17 and a maximum of 102.

    Time frame: Baseline (prior to treatment), post-treatment (within 30 days of treatment completion) and follow-up (1 year after treatment completion)

Secondary outcomes

  1. Changes in child emotional and behavioural challenges between baseline, post-treatment, and follow-up

    This will be assessed using the Behavior and Feelings Scale (BFS) which asks parents to indicate how big of a problem a behaviour or feeling has been for a child in the last two weeks from '0 - not a problem' to '4 - a very big problem'.

    Time frame: Baseline (prior to treatment), post-treatment (within 30 days of treatment completion) and follow-up (1 year after treatment completion)

  2. Changes in child emotional and behavioural challenges between baseline, post-treatment, and follow up

    This will be assessed using the Child Behavior Checklist (CBCL) which asks parents to indicate how relevant the listed challenges are to their child from '0 - not true', '1 - somewhat or sometime true', and '2 - very or often true'.

    Time frame: Baseline (prior to treatment), post-treatment (within 30 days of treatment completion) and follow-up (1 year after treatment completion)

  3. Changes in child emotional and behavioural challenges between baseline, post-treatment, and follow up

    This will be assessed using the Modified Connors which asks parents to indicate how much a concerning behaviour describes their child from 'not at all', 'just a little', 'pretty much', or 'very much'.

    Time frame: Baseline (prior to treatment), post-treatment (within 30 days of treatment completion) and follow-up (1 year after treatment completion)

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Lochman JE, Wells KC. The coping power program for preadolescent aggressive boys and their parents: outcome effects at the 1-year follow-up. J Consult Clin Psychol. 2004 Aug;72(4):571-8. doi: 10.1037/0022-006X.72.4.571. PubMed 15301641 ↗
  • Lochman, J.E. and K.C. Wells, Effectiveness of the Coping Power Program and of Classroom Intervention With Aggressive Children: Outcomes at a 1-Year Follow-Up. Behavior Therapy, 2003. 34: p. 493-515.
  • Andrade, B.F., et al., The clinic-adapted coping power program and individualized child and family treatment: A randomized and controlled effectiveness trial. Journal of Child Psychology and Psychiatry, 2015. Submitted.
  • Lochman JE, Powell N, Boxmeyer C, Andrade B, Stromeyer SL, Jimenez-Camargo LA. Adaptations to the coping power program's structure, delivery settings, and clinician training. Psychotherapy (Chic). 2012 Jun;49(2):135-42. doi: 10.1037/a0027165. PubMed 22642521 ↗

Individual participant data

Plan to share: No — Would need further REB approval to determine whether participant data could be released based on existing consent.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2016 to primary completion in Sep 2022, 72 months.

Of 22 interventional studies with no phase under Attention Deficit and Disruptive Behavior Disorders, half reached primary completion within 39 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 68. This study's 72 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 28, 2024
First posted
Mar 27, 2026
StartActual
Sep 1, 2016
Primary completionActual
Sep 1, 2022
CompletionActual
Jul 1, 2023
Last update
Mar 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07495683
Responsible party
Brendan Andrade (Associate Professor, Centre for Addiction and Mental Health) — Principal investigator
First posted
Mar 27, 2026
Start date
Sep 1, 2016
Primary completion
Sep 1, 2022
Completion
Jul 1, 2023
Last update
Mar 27, 2026

Study contacts

Brendan F. Andrade, Dr.
principal investigator · Centre for Addiction and Mental Health

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion